A Gene Therapy company with a goal to bring transformative genetic medicine to patients worldwide faster and at a low cost

YuanMing Capital is a healthcare specialty fund focusing on China-US cross border investments with offices in Beijing and New York City. The investment team has rich industry experience and a successful investment track record. The fund invests in therapeutics, medical devices, diagnostics as well as healthcare service companies based in US and/or China.

One of China's leading securities companies

Tus-Holdings Co., Ltd. (hereinafter referred to as TusHoldings), set up on July, 2000, is the former Tsinghua University Science Park (TusPark) Development Center founded in August 1994. TusHoldings is an S&T investment holdings group established in reliance on Tsinghua University focusing on S&T services. It takes full responsibility for developing, constructing, operating and managing TusPark, and it’s one of the first National Demonstration Enterprises in modern service industry. It’s the controlling shareholder or shareholder of over 800 listed & non-listed enterprises,including TUS-PHARMA, TUS-EST, 21Vianet Group, BIOREM, TUS INTERNATIONAL, TUS-DESIGN, NSFOCUS, ChineseAll, Beijing Enterprises Clean Energy, GigaDevice, CICTEC , Tus-Tuwei ,etc., and the total assets under its management is nearly RMB 200 billion.